Niederkorn Jerry Y
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas 75390-9057, USA.
Curr Eye Res. 2007 Dec;32(12):1005-16. doi: 10.1080/02713680701767884.
Penetrating keratoplasty has been successfully performed on humans for over 100 years and remains the most common form of solid tissue transplantation. Although corneal allografts enjoy a remarkable degree of immune privilege, immune rejection remains the leading cause of keratoplasty failure. The immunologic basis for corneal allograft rejection was established in animal studies over 50 years ago, yet large gaps remain in our knowledge regarding the cellular and molecular mechanisms of corneal allograft rejection. The enormous redundancy in the mammalian immune system creates a condition that favors the development of multiple independent immune mechanisms that can produce corneal allograft rejection. Although there are few absolute principles, it is certain that the immune rejection of corneal allografts is (1) T cell-dependent, (1) heavily dependent upon CD4(+) T cells, (3) not restricted to either Th1 or Th2 T cell populations, and (4) dependent upon an intact repertoire of resident antigen presenting cells.
穿透性角膜移植术已在人类身上成功施行超过100年,并且仍然是实体组织移植最常见的形式。尽管角膜同种异体移植享有显著程度的免疫赦免,但免疫排斥仍然是角膜移植失败的主要原因。角膜同种异体移植排斥的免疫学基础在50多年前的动物研究中就已确立,但在我们关于角膜同种异体移植排斥的细胞和分子机制的知识方面仍存在很大差距。哺乳动物免疫系统中存在的巨大冗余创造了一种有利于多种独立免疫机制发展的条件,这些机制可导致角膜同种异体移植排斥。虽然几乎没有绝对的原则,但可以确定的是,角膜同种异体移植的免疫排斥(1)依赖于T细胞,(2)严重依赖于CD4(+) T细胞,(3)不限于Th1或Th2 T细胞群体,并且(4)依赖于完整的驻留抗原呈递细胞库。